Try our Advanced Search for more refined results
Corporate
-
March 25, 2026
Mom Tying Abbott Formula To Baby's NEC Takes The Stand
A plaintiff claiming Abbott Laboratories' preterm baby formula contributed to her infant's development of a serious gut condition told an Illinois jury Wednesday that she wouldn't have allowed her baby to consume the formula had she known it increased the risk of the infection, saying her now-teenage daughter still struggles with medical complications as a result.
-
March 25, 2026
Estate Says OpenAI Suicide Suit Distinct From Murder Suit
The estate of a man who murdered his mother and died by suicide allegedly because of his use of ChatGPT is urging a California federal court not to dismiss its suit against OpenAI, saying the suit doesn't run parallel to a state court case from the mother's estate.
-
March 25, 2026
Lender Targets Borrower, Guarantor In $3.8M Default Suit
A Delaware lender has sued a group of real estate investors and affiliated entities in Delaware Chancery Court, accusing them of defaulting on a $3.8 million mezzanine loan and then diverting collateral to avoid repayment.
-
March 25, 2026
Turf Company Executive Can't Escape Trade Secrets Suit
An executive must face a turf manufacturer's suit claiming he took confidential information with him when he jumped ship for a rival company, a Georgia federal judge ruled, but said a lack of plausible misconduct allegations meant that rival should be dismissed from the case.
-
March 25, 2026
Ashurst Adds 4 Ex-Bracewell Partners To Finance Practice
Ashurst LLP has announced the addition of a four-partner team in New York to expand its finance and restructuring capacities ahead of a proposed merger with Perkins Coie LLP.
-
March 25, 2026
Judge Trims SEC Fraud Case Over Cancer Drug Claims
A Massachusetts federal judge greenlighted U.S. Securities and Exchange Commission claims against two of three former pharmaceutical executives accused of concealing from investors the U.S. Food and Drug Administration's "harsh critiques" about a cancer drug.
-
March 25, 2026
Insurer Need Not Cover Parkinson's Drug Antitrust Dispute
An insurer does not owe coverage in an antitrust suit accusing a pharmaceutical company of suppressing generic versions of the Parkinson's treatment Apokyn, a Maryland federal judge ruled, finding the dispute does not involve "securities claims" covered under the insurer's policy.
-
March 25, 2026
Del. Chancellor Pauses Tesla Suit As Musk Cites LinkedIn Post
The Delaware Chancery Court has paused a high-profile Tesla stockholder case following a recusal bid from Elon Musk and Tesla Inc. after a judge's LinkedIn account appeared to react to a post celebrating a recent California jury verdict against Musk, including language praising efforts to stand up to "the richest man in the world."
-
March 25, 2026
Utah Expands Unrelated Biz Income Definition For Corp. Tax
Utah will expand its definition of corporate income to include income allocated to the state under a bill signed by the state's governor.
-
March 25, 2026
Jury Doubles Damages Against Meta, Google In LA Bellwether
A California state jury that found Meta and Google liable Wednesday for harming the mental health of a woman who says she became addicted to their social media platforms as a child delivered a second blow later in the day, awarding $3 million in punitive damages on top of a $3 million compensatory award.
-
April 01, 2026
White & Case Expands In Brussels With Amazon Hire
White & Case LLP has recruited a senior in-house lawyer at Amazon for its office in Brussels, the law firm's latest technology-focused hire globally.
-
March 25, 2026
High Court Reverses Music Piracy Liability Ruling Against Cox
The U.S. Supreme Court on Wednesday said the Fourth Circuit incorrectly affirmed a jury verdict that found Cox Communications liable for its customers' music piracy, concluding there is a legal distinction between mere knowledge of infringement and intent to promote it.
-
March 24, 2026
Pentagon 'Punishing' Anthropic Would Be Illegal, Judge Says
A California federal judge considering Anthropic's request to block the U.S. Department of Defense from labeling it a supply chain national security risk said Tuesday that it looks like the government is "punishing" Anthropic for bringing public attention to their contract fight, a move that would violate the First Amendment.
-
March 24, 2026
Meta Tackles Borrowed Underwear Analogy In Privacy Suit
A California federal judge mulling Meta's argument that its users' consent bars a proposed privacy class action pressed Meta's lawyers Tuesday on whether social expectations affect the bounds of that consent, observing that if she gave a friend permission to borrow her clothes, "I don't expect her to borrow my underwear."
-
March 24, 2026
Iowa Asks 5th Circ. To Ax 'Uncertain' Schwab Antitrust Deal
Iowa's attorney general Monday pressed the Fifth Circuit to reject investors' deal with The Charles Schwab Corp. in an antitrust suit over its merger with TD Ameritrade, arguing it offers only uncertain and hypothetical relief to class members while giving named plaintiffs and class counsel a "windfall."
-
March 24, 2026
AI Tools May 'Disrobe' Meta Of Section 230 Shield, Judge Says
A California federal judge trimmed Tuesday a proposed class action alleging Meta Platforms Inc. knowingly participated in a Chinese pump-and-dump scheme advertised on social media, but found there's a factual dispute over whether Meta's AI tools materially contributed to the "facially ridiculous" ads.
-
March 24, 2026
FINRA CEO Highlights New Clearinghouse For Cyber Threats
Robert Cook, CEO of the Financial Industry Regulatory Authority, said Tuesday that it will soon be rolling out a clearinghouse for firms to report cybersecurity threats and to promote information sharing across the industry.
-
March 24, 2026
Drug Co. Atara Hit With Investor Suit Over FDA Denial
Drug company Atara Biotherapeutics Inc. has been hit with a proposed class action accusing it of harming investors by not disclosing certain manufacturing problems and research study deficiencies that made it unlikely the U.S. Food and Drug Administration would approve its new drug application.
-
March 24, 2026
Delaware Court Tosses Allied Gaming Suit, Awards $5.9M Fees
The Delaware Chancery Court on Tuesday dismissed a stockholder challenge to a disputed share issuance at Allied Gaming & Entertainment Inc. as moot, while ordering the company to pay nearly $5.94 million in attorney fees and expenses after finding that the litigation prompted the company to reverse course.
-
March 24, 2026
Sarepta Urges Full Fed. Circ. To Wipe Out Gene Therapy IP
Sarepta Therapeutics Inc. wants the full Federal Circuit to rethink a decision reviving a University of Pennsylvania gene therapy patent, saying a panel got its analysis of patent eligibility wrong.
-
March 24, 2026
Compliance Chiefs Offer Insight On AI In Financial Services
JPMorgan Chase & Co.'s chief compliance officer said Tuesday that artificial intelligence has proven "transformative" to her bank, and that she sees a time when compliance officers may come to supervise AI agents as the technology evolves.
-
March 24, 2026
Publishers Say Anthropic's Use Of Lyrics Violates Copyrights
Music publishers have asked a California federal judge to rule that Anthropic infringed their copyrighted song lyrics through its Claude large language model, arguing in a motion for partial summary judgment that fair use does not excuse the AI developer's conduct because it used those lyrics to build a competing commercial product.
-
March 24, 2026
Crypto Project Execs Escape Investors' Fraud, RICO Suit
A Tennessee federal judge has dismissed the alleged co-CEO and other executives of purported crypto projects from a suit accusing them of duping investors out of tens of millions of dollars with false promises of returns, finding the investors do not plausibly plead their fraud or racketeering claims.
-
March 24, 2026
Ga. Exec Cops To Role In Alleged $380M Ponzi Scheme
The former chief administrative officer of an Atlanta-area financial advisory group pled guilty Tuesday to one count of money laundering in connection to her role in what prosecutors said was a $380 million Ponzi scheme.
-
March 24, 2026
Meta Owes $375M In NM Trial Over Harm To Teens
A New Mexico jury said Tuesday that Meta must pay $375 million over the state attorney general's bellwether claims that the social media giant hid the full scope of mental health harm its apps were causing to underage users.
Expert Analysis
-
The SEC Whistleblower Program A Year Into 2nd Trump Admin
The U.S. Securities and Exchange Commission's whistleblower program continues to operate as designed, but its internal cadence, scrutiny of claims and operational structure reflect a period of recalibration, with precision mattering more than ever, say attorneys Scott Silver and David Chase.
-
Key Crypto Class Action Trends And Rulings In 2025
As the law continued to take shape in the growing area of crypto-assets, this year saw a jump in crypto class action litigation, including noteworthy decisions on motions to compel arbitration and class certification, according to Justin Donoho at Duane Morris.
-
Calling The AI Witness In 2026's Merger Reviews
Organizations that anticipate facing a second request or merger clearance review in 2026 should collect artificial intelligence artifacts as part of discovery, and distinguish between human-generated and machine-generated materials, says Sean McDermott at FTI Consulting.
-
How New SEC Policies Shift Shareholder Proposal Landscape
U.S. Securities and Exchange Commission Chairman Paul Atkins' recent remarks provide a road map for public companies to exclude nonbinding shareholder proposals from proxy materials, which would disrupt the mechanism that has traditionally defined how shareholders and companies engage on governance matters, say attorneys at Gunderson.
-
Series
Knitting Makes Me A Better Lawyer
Stretching my skills as a knitter makes me a better antitrust attorney by challenging me to recalibrate after wrong turns, not rush outcomes, and trust that I can teach myself the skills to tackle new and difficult projects — even when I don’t have a pattern to work from, says Kara Kuritz at V&E.
-
How 11th Circ.'s Qui Tam Review Could Affect FCA Litigation
On Dec. 12, the Eleventh Circuit will hear arguments in U.S. ex rel. Zafirov v. Florida Medical Associates, setting the stage for a decision that could drastically reduce enforcement under the False Claims Act, and presenting an opportunity to seek U.S. Supreme Court review of the act's whistleblower provisions, say attorneys at Epstein Becker.
-
Series
The Biz Court Digest: Welcome To Miami
After nearly 20 years in operation, the Miami Complex Business Litigation Division is a pioneer upon which other jurisdictions in the state have been modeled, adopting many innovations to keep its cases running more efficiently and staffing experienced judges who are accustomed to hearing business disputes, say attorneys at King & Spalding.
-
Recent Proposals May Spell Supervision Overhaul For Banks
A slew of rules recently proposed by the federal banking agencies with approaching comment deadlines would rewrite supervision standards to be further tailored to banks' size and activities, while prioritizing financial risks over process, documentation and other nonfinancial risks, say attorneys at Davis Wright.
-
What US Can Learn From Brazil's Securities Arbitration Model
To allay investor concerns about its recent approval of mandatory arbitration clauses in public company registration statements, the U.S. Securities and Exchange Commission should look to Brazil's securities arbitration model, which shows that clear rules and strong institutions can complement the goals of securities regulation, say arbiters at the B3 Arbitration Chamber.
-
Navigating The New Patchwork Of Foreign-Influence Laws
On top of existing federal regulations, an expanding wave of state legislation — placing new limits on foreign-funded political spending and new registration requirements for foreign agents — creates a confusing compliance backdrop for corporations that demands careful preplanning, say attorneys at BakerHostetler.
-
AI Evidence Rule Tweaks Encourage Judicial Guardrails
Recent additions to a committee note on proposed Rule of Evidence 707 — governing evidence generated by artificial intelligence — seek to mitigate potential dangers that may arise once machine outputs are introduced at trial, encouraging judges to perform critical gatekeeping functions, say attorneys at Lankler Siffert & Wohl.
-
Terrorist Label For Maduro Poses New Risks For US Firms
The State Department's recent designation of President Nicolás Maduro, and other Venezuelan government and military officials, as members of a foreign terrorist organization drastically increases the level of caution companies must exercise when doing business in the region to mitigate potential civil, criminal and regulatory risk, say attorneys at Freshfields.
-
Series
The Law Firm Merger Diaries: Getting The Message Across
Communications and brand strategy during a law firm merger represent a crucial thread that runs through every stage of a combination and should include clear messaging, leverage modern marketing tools and embrace the chance to evolve, says Ashley Horne at Womble Bond.
-
2 Early Settlement Alternatives In Federal Securities Litigation
Most class actions brought under the federal securities laws are either settled or won by the defendants following a motion to dismiss, but two alternative strategies have the potential to lower discovery costs and allow defendants to obtain judgment without the uncertainty of jury trials on complex matters, says Richard Zelichov at DLA Piper.
-
Opinion
Horizontal Stare Decisis Should Not Be Casually Discarded
Eliminating the so-called law of the circuit doctrine — as recently proposed by a Fifth Circuit judge, echoing Justice Neil Gorsuch’s concurrence in Loper Bright — would undermine public confidence in the judiciary’s independence and create costly uncertainty for litigants, says Lawrence Bluestone at Genova Burns.